RedHill Biopharma Ltd.
Serine protease inhibitor for treating coronavirus infection
Last updated:
Abstract:
The disclosure is directed to WX-671, as (L)- or (D)-enantiomers, and as E- or (Z)-isomers or (E/Z)-mixtures, and as free bases or as salts thereof, in preparing medicines for treating coronavirus infection or preventing diseases caused by coronavirus infection, and a medicine for preventing coronavirus infection or preventing diseases caused by coronavirus infection.
Status:
Grant
Type:
Utility
Filling date:
8 Mar 2021
Issue date:
29 Jun 2021